Product Information
PITAVASTATIN 1 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $1.2002 per EA under NDC 00832604890. Its NADAC has been published 123 times since Feb 21, 2024.
Strength
1 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832604890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205955On Market Since
11/2/2023
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 1 MG TABLET has been published 123 times since Feb 21, 2024, and over the history we have for it it has declined 48.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2002 per EA |
|---|---|
| All-time high | $2.3862 (Apr 10, 2024) |
| All-time low | $1.1616 (Mar 18, 2026) |
| 52-week high | $1.6105 |
| 52-week low | $1.1616 |
| Median price | $1.6025 |
| Average price | $1.6604 |
| Largest weekly change | +23.0% (Jun 19, 2024) |
| Weeks tracked | 123 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Pitavastatin Calcium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PITAVASTATIN 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 1 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $1.2002 per EA (NDC 00832604890), effective Jun 24, 2026.
How has the price of PITAVASTATIN 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 1 MG TABLET has declined 48.0%. It has been tracked across 123 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 1 MG TABLET?
Since Feb 21, 2024, the NADAC for PITAVASTATIN 1 MG TABLET has ranged from a low of $1.1616 (Mar 18, 2026) to a high of $2.3862 (Apr 10, 2024), with a median of $1.6025 per EA.
Are there cheaper alternatives to PITAVASTATIN 1 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PITAVASTATIN 1 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PITAVASTATIN 1 MG TABLET?
PITAVASTATIN 1 MG TABLET (NDC 00832604890) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification